Driving Innovation in Early Cancer Detection
Date: 9 February 2026
Venue: Institute of Medical Research Setia Alam
Strengthening Collaboration in Medical Research
MyRNA Diagnostics Sdn. Bhd. conducted a working visit to the Institute of Medical Research (IMR), under the Ministry of Health Malaysia, as part of its ongoing efforts to foster collaboration in advancing healthcare innovation.
The visit provided a valuable platform to engage with one of Malaysia’s leading medical research institutions, focusing on opportunities to enhance early detection and precision diagnostics through strategic partnerships.
Introducing miRNA-Based Early Cancer Screening
During the session, MyRNA introduced its miRNA-based early cancer screening platform, a cutting-edge approach leveraging molecular biomarkers to detect cancer at earlier, more treatable stages.
Key highlights of the platform include:
- Non-invasive screening approach, improving patient accessibility and compliance
- High sensitivity and specificity, enabling earlier and more accurate detection
- Data-driven insights, supporting clinical decision-making and population health strategies
- Scalability for nationwide screening programs, aligned with public health initiatives
This technology represents a significant step forward in transforming cancer detection from reactive treatment to proactive prevention and early intervention.
Advancing Research and Public Health Outcomes
The engagement with IMR underscores MyRNA’s commitment to bridging innovation and research with real-world healthcare applications. Potential areas of collaboration discussed include:
- Joint research initiatives in molecular diagnostics
- Validation and localization of screening technologies for Malaysian populations
- Integration into national health screening frameworks
- Knowledge exchange and capacity building in advanced diagnostics
Such collaborations are essential in strengthening Malaysia’s ability to respond to the growing burden of non-communicable diseases, particularly cancer.
Looking Ahead
The working visit marks an important step towards building a collaborative ecosystem between MyRNA and the Ministry of Health’s research arm. By aligning innovation with national healthcare priorities, MyRNA aims to contribute to a future where early detection becomes the standard of care.
